Evidence map›Paper›PMID 33921903›Full record

ArticlePharmaceutics2021

ELISA- and Activity Assay-Based Quantification of BMP-2 Released

Julius Sundermann, Steffen Sydow, Laura Burmeister, Andrea Hoffmann, Henning Menzel, Heike Bunjes

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Julius SundermannTechnische Universität Braunschweig, Institut für Pharmazeutische Technologie und Biopharmazie, 38106 Braunschweig, Germany.ORCID 0000-0001-8731-0770
Steffen SydowTechnische Universität Braunschweig, Institut für Technische Chemie, 38106 Braunschweig, Germany.
Laura BurmeisterNiedersächsisches Zentrum für Biomedizintechnik, Implantatforschung und Entwicklung (NIFE), 30625 Hannover, Germany.
Andrea HoffmannNiedersächsisches Zentrum für Biomedizintechnik, Implantatforschung und Entwicklung (NIFE), 30625 Hannover, Germany.ORCID 0000-0003-2318-8985
Henning MenzelTechnische Universität Braunschweig, Institut für Technische Chemie, 38106 Braunschweig, Germany.ORCID 0000-0002-4915-7311
Heike BunjesTechnische Universität Braunschweig, Institut für Pharmazeutische Technologie und Biopharmazie, 38106 Braunschweig, Germany.ORCID 0000-0002-8670-6076
Technische Universität Braunschweig · DEMedizinische Hochschule Hannover · DE

Funding

Deutsche Forschungsgemeinschaft FOR 2180Niedersächsisches Ministerium für Wissenschaft und Kultur Smart BioTecs alliance
6 · The paper itself

Abstract

Chitosan nanogel-coated polycaprolactone (PCL) fiber mat-based implant prototypes with tailored release of bone morphogenic protein 2 (BMP-2) are a promising approach to achieve implant-mediated bone regeneration. In order to ensure reliable

Indexed as

BMP-2bone morphogenetic protein 2chitosanmatrix effectsrelease quantification

Identifiers

PMID33921903
PMCPMC8073737
OpenAlexW3155191358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.